View PDF

Improvement of a potential anthrax therapeutic by computational protein design

Sean J. Wu, Christopher B. Eiben, John H. Carra, Ivan Huang, David Zong, Peixian Liu, Cindy T. Wu, Jeff Nivala, Josef Dunbar, Tomas Huber, Jeffrey Senft, Rowena Schokman, Matthew D. Smith, Jeremy H. Mills, Arthur M. Friedlander, David Baker, and Justin B. Siegel

References

1.

. Committee to Assess the Safety and Efficacy of the Anthrax Vaccine. 2002.

2.

A P Pomerantsev, N A Staritsin, V Yu, L I Marinin. Vaccine. 1997.

3.

A V Stepanov, L I Marinin, A P Pomerantsev, N A Staritsin. J Biotechnol. 1996.

4.

T V Inglesby, T O'toole, D A Henderson, J G Bartlett, M S Ascher, E Eitzen, A M Friedlander, J Gerberding, J Hauer, J Hughes, J Mcdade, M T Osterholm, G Parker, T M Perl, P K Russell, K Tonat. JAMA : the journal of the American Medical Association. 2002.

5.

B D Green, L Battisti, T M Koehler, C B Thorne, B E Ivins. Infect Immun. 1985.

6.

P Mikesell, B E Ivins, J D Ristroph, T M Dreier. Infect Immun. 1983.

7.

A Scorpio, D J Chabot, W A Day, D O'brien, K Vietri, N J Itoh, Y Mohamadzadeh, M Friedlander, A M. Antimicrob Agents Chemother. 2007.

8.

T Candela, A Fouet. Mol Microbiol. 2005.

9.

A Scorpio, S A Tobery, W J Ribot, A M Friedlander. Antimicrob Agents Chemother. 2008.

10.

A Scorpio, D J Chabot, W A Day, T A Hoover, A M Friedlander. Microbiology. 2010.

11.

R Wu, S Richter, R G Zhang, V J Anderson, D Missiakas, Joachimiak, A. J Biol Chem. 2009.

12.

K T Simons, C Kooperberg, E Huang, D Baker. Journal of molecular biology. 1997.

13.

A Leaver-Fay, M Tyka, S M Lewis, O F Lange, J Thompson, R Jacak, K Kaufman, P D Renfrew, C A Smith, W Sheffler, I W Davis, S Cooper, A Treuille, D J Mandell, F Richter, Y E Ban, S J Fleishman, J E Corn, D E Kim, S Lyskov, M Berrondo, S Mentzer, Z Popovic, J J Havranek, J Karanicolas, R Das, J Meiler, T Kortemme, J J Gray, B Kuhlman, D Baker, P Bradley. Methods Enzymol. 2011.

14.

T A Kunkel. Proc Natl Acad Sci U S A. 1985.

15.

T Y Zakharian, S R Coon. Comput Chem. 2001.

16.

B Kuhlman, D Baker. Proceedings of the National Academy of Sciences of the United States of America. 2000.

17.

W T Lowther, B W Matthews. Journal of immunotherapy. 1997.

18.

Y Yu, S Lutz. Trends Biotechnol. 2011.

19.

S S Tate, A Meister. Mol Cell Biochem. 1981.

20.

R B Silverman. London 22. Delano, W. L. The PyMOL Molecular Graphics System Supplemental Figure S8. Serum Dependence of Synthetic PDGA Cleavage. Each enzyme was incubated at several different concentrations of mouse serum, as indicated in the Figure. The relative rate of PDGA cleavage was measured and plotted as a function of serum concentration. 2002.

Backlinks

1.

<p>Improvement of a potential anthrax therapeutic by computational protein design</p>.